Consider clinically relevant pharmacokinetic drug interactions when co-prescribing drugs in attention-deficit/hyperactivity disorder
Crossref DOI link: https://doi.org/10.1007/s40267-020-00749-3
Published Online: 2020-05-30
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Esther
Heo, Young-A.
Text and Data Mining valid from 2020-05-30
Version of Record valid from 2020-05-30
Article History
First Online: 30 May 2020
Compliance with ethical standards
:
: EK and YAH are contracted or salaried employees of Adis International Ltd./Springer Nature and declare no relevant conflicts of interest.